Companies: 10,795·Total market cap: $144.5T
Genelux Corporation

Genelux Corporation

GNLXNASDAQHealthcare● Active
$2.93
+$0.00(+0.00%)
Market Cap$110217535
P/E Ratio
52W High$8.535
52W Low$2.29
Overview

Genelux Corporation(GNLX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GNLX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.01M$0.01M$0.17M$11.07M$0.00M
Cost of Revenue$0.57M$0.90M$1.02M$0.97M$0.90M
Gross Profit($0.57M)($0.90M)($0.85M)$10.10M($0.90M)
Gross Margin %(computed)-498.82%91.25%
Operating Expenses
R&D Expenses$19.85M$19.00M$12.77M$9.08M$6.32M
G&A Expenses$13.37M$12.71M$11.57M$5.00M$8.29M
Total Operating Expenses$32.65M$30.80M$23.32M$13.11M$13.72M
Operating Income($33.21M)($31.70M)($24.16M)($3.01M)($14.61M)
Operating Margin %(computed)-27.22%
Interest Income$1.07M$1.46M$0.24M$0.00M$0.00M
Interest Expense$0.00M$0.00M$3.97M$1.41M$1.81M
Income Before Tax($32.15M)($29.87M)($28.30M)($4.11M)($16.38M)
Income Tax Expense$0.00M$0.00M$0.00M$1.10M$0.00M
Net Income($32.15M)($29.87M)($28.30M)($5.21M)($17.80M)
Net Margin %(computed)-47.05%
Per Share & EBITDA
EPS (Basic)$-0.86$-0.95$-1.16$-0.21$-0.69
Wtd Avg Shares37.18M31.45M24.43M24.55M23.62M
EBITDA($32.64M)($28.97M)($26.46M)($1.73M)($13.67M)
EBITDA Margin %(computed)-15.64%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Genelux Corporation

关于Genelux Corporation(GNLX)损益表

Genelux Corporation(GNLX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,GNLX实现营收$0.00B,毛利润($0.00B)(毛利率-7075.00%),净利润($0.03B)(净利率-401812.50%)。

常见问题

GNLX · 4 问

Genelux Corporation(GNLX)2025财年营收为$0.00B,同比down0.0%。

GNLX revenueGNLX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09